Faculty Publications 2020

  1. Witek N, Afshari M, Liu Y, Ouyang B, Hall D. Inpatient versus outpatient evaluation of suspected paraneoplastic cerebellar degeneration. Neurology Clinical Practice. 2021 Feb;11(1):33-42. doi: 10.1212/CPJ.0000000000000854. PMID: 33968470 PMCID: PMC8101295.
  2. Patel RA, Joyce J, Witek N, Afshari M. GAD65 antibody-associated neurologic disease presenting with hemiparkinsonism at onset. Neurology Clinical Practice. published online October 19, 2020.
  3. Afshari M, Ostrem J, Starr P. Bilateral ventralis intermedius (Vim) thalamic deep brain stimulation (DBS) for medication-refractory orthostatic tremor. Deep Brain Stimulation: A Case-Based Approach. In: Chitnis S, Khemani P, Okun M, eds. Oxford University Press. June 2020.
  4. Afshari M, Ostrem J, San Luciano M, Larson P.  Rescue ventralis intermedius (Vim) thalamic deep brainstimulation (DBS) to address refractory tremor following subthalamic nucleus (STN) DBS with brittle stimulation-induced dyskinesia.  Deep Brain Stimulation: A Case-Based Approach. In: Chitnis S, Khemani P, Okun M, eds.  Oxford University Press. June 2020.
  5. Patel RA, Hall DA, Eichenseer S, Bailey M. Movement Disorders and Hematologic Diseases. Mov Disord Clin Pract. 2020 Dec 29;8(2):193-207. doi: 10.1002/mdc3.13129. PMID: 33553488; PMCID: PMC7853188.
  6. Bailey M, Anderson S, Hall DA. Parkinson’s Disease in African Americans: A Review of the Current Literature. J Parkinsons Dis. 2020;10(3):831-841. doi: 10.3233/JPD-191823. PMID: 32417794; PMCID: PMC7458499.
  7. Johnstone T, Wang J, Ross D, Balanda N, Huang Y, Godfrey R, Groden C, Barton BR, et al. Biallelic variants in two complex I genes cause abnormal splicing defects in probands with mild Leigh syndrome. Molecular Genetics and Metabolism. 2020;13198-106. doi:10.1016/j.ymgme.2020.09.008 PMID: 33097395
  8. Radder DLM, Nonnekes J, van Nimwegen M, Eggers C, Abbruzzese G, Alves G, Browner N, Chaudhuri KR, Ebersbach G, Ferreira JJ, Fleisher JE, et al. Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson’s Disease. J Parkinsons Dis. 2020;10(3):1087-1098. doi: 10.3233/JPD-202078. PMID: 32444563; PMCID: PMC7415700.
  9. Fleisher JE, et al. Interdisciplinary palliative care for people with advanced Parkinson’s disease: a view from the home. Ann Palliat Med. 2020 Feb;9(Suppl 1):S80-S89. doi: 10.21037/apm.2019.09.12. Epub 2019 Oct 14. PMID: 31735037; PMCID: PMC7341729.
  10. Feeney M, Evers C, Agpalo D, Cone L, Fleisher J, et al. Utilizing patient advocates in Parkinson’s disease: A proposed framework for patient engagement and the modern metrics that can determine its success. Health Expect. 2020 Aug;23(4):722-730. doi: 10.1111/hex.13064. Epub 2020 May 3. Erratum in: Health Expect. 2020 Aug;23(4):976. PMID: 32363785; PMCID: PMC7495075.
  11. Cone L, Feeney M, Evers C, Agpalo D, Fleisher J, et al. Partnering to power progress towards a paradigm shift: Response to Riggare et al. Health Expect. 2020 Aug;23(4):974-975. doi: 10.1111/hex.13126. PMID: 32939945; PMCID: PMC7495060.
  12. Fleisher JE, Sennott BJ, Myrick E, Niemet CJ, Lee M, Whitelock CM, Sanghvi M, Liu Y, Ouyang B, Hall DA, Comella CL, Chodosh J. KICK OUT PD: Feasibility and quality of life in the pilot karate intervention to change kinematic outcomes in Parkinson’s Disease. PLoS One. 2020 Sep 9;15(9):e0237777. doi: 10.1371/journal.pone.0237777. PMID: 32903267; PMCID: PMC7480843.
  13. Sennott B, Woo K, Hess S, Mitchem D, Klostermann EC, Myrick E, Savica R, Fleisher JE. Novel Outreach Program and Practical Strategies for Patients with Parkinsonism in the COVID-19 Pandemic. J Parkinsons Dis. 2020;10(4):1383-1388. doi: 10.3233/JPD-202156. PMID: 32804103; PMCID: PMC7606485.
  14. Fleisher JE, et al. Disease severity and quality of life in homebound people with advanced Parkinson disease: A pilot study. Neurol Clin Pract. 2020 Aug;10(4):277-286. doi: 10.1212/CPJ.0000000000000716. PMID: 32983607; PMCID: PMC7508339.
  15. Faust-Socher A, Anis S, Kestenbaum M, Shabtai H, Taichman T, David AB, Ezra A, Peretz C, Rosenberg A, Brozgol M, Herman T, Glenn T Stebbins GT, Goetz CG, et al. Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale. Neuroepidemiology 2020 July;54(4):356-361.
  16. Hyczy de Siqueira Tosin M, Goetz CG, Luo S, Choi D, Stebbins GT. Item Response Theory Analysis of the MDS-UPDRS Motor Examination: Tremor vs. Nontremor Items. Mov Disord. 2020 Sep;35(9):1587-1595.
  17. Goetz CG, Stebbins GT, et al. Movement Disorder Society–Unified Parkinson’s Disease Rating Scale Use in the Covid-19 Era. Mov Disord. 2020 June;35(6):911.
  18. Diederich NJ, Uchihara T, Grillner S, Goetz CG. The Evolution-Driven Signature of Parkinson’s Disease. Trends Neurosci. 2020 Jul;43(7):475-492.
  19. Tosin MHS, Stebbins GT, Goetz CG, et al. Measuring Medication Adherence in Parkinson’s Disease: A Systematic Review of Contributing Components in Rating Scales. Mov Disord Clin Pract. 2020 Jul 8;7(6):607-615.
  20. O’Keefe JA, Bang D, Robertson EE, Biskis A, Ouyang B, Liu Y, Pal G, Berry-Kravis E, Hall DA. Prodromal Markers of Upper Limb Deficits in FMR1 Premutation Carriers and Quantitative Outcome Measures for Future Clinical Trials in Fragile X-associated Tremor/Ataxia Syndrome. Movement Disorders Clinical Practice. 2020;7810-819. doi:10.1002/mdc3.13045 PMID: None
  21. Rezvanian S, Litvan I, Standaert D, Jankovic J, Reich SG, Hall D, et al. Understanding the relationship between freezing of gait and other progressive supranuclear palsy features. Parkinsonism and Related Disorders. 2020;7856-60. doi:10.1016/j.parkreldis.2020.07.009 PMID: 32731191
  22. Hall DA, et al. Fragile X Gray Zone Alleles Are Associated With Signs of Parkinsonism and Earlier Death. Movement Disorders. 2020;351448-1456. doi:10.1002/mds.28086 PMID: 32463542
  23. Hill EJ, Goetz CG, Stebbins GT, Hagerman R, Ouyang B, Hall DA. Placebo Response in Fragile X-associated Tremor/Ataxia Syndrome. Movement Disorders Clinical Practice. 2020;7298-302. doi:10.1002/mdc3.12919 PMID: None
  24. Hall DA, Robertson EE, Leehey M, McAsey A, Ouyang B, Berry-Kravis E, O Keefe JA. Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS). PLoS ONE. 2020;15doi:10.1371/journal.pone.0225191 PMID: 32053612
  25. O Keefe JA, Guan J, Robertson E, Biskis A, Joyce J, Ouyang B, Liu Y, Carnes D, Purcell N, Berry-Kravis E, Hall DA. The Effects of Dual Task Cognitive Interference and Fast-Paced Walking on Gait, Turns, and Falls in Men and Women with FXTAS. Cerebellum. 2020;doi:10.1007/s12311-020-01199-3 PMID: None
  26. Napier TC, Kirby A, et al. The role of dopamine pharmacotherapy and addiction-like behaviors in Parkinson’s disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2020;102doi:10.1016/j.pnpbp.2020.109942 PMID: 32272129
  27. Hebert C, Behel J, Stebbins G, Pal G, Kasi R, Kompoliti K.  Multidisciplinary Inpatient Rehabilitation for Functional Movement Disorders: A Prospective Study with Long Term Follow-Up. Parkinsonism and Related Disorder. 2020 Nov 21;82:50-55. doi: 10.1016/j.parkreldis.2020.11.018.
  28. Mahajan A, et al. Tremor-Dominant Cervical Dystonia: a Cerebellar Syndrome. Cerebellum. 2020 Nov 7. doi: 10.1007/s12311-020-01211-w. Epub ahead of print. PMID: 33161481.
  29. Espay AJ, Marsili L, Mahajan A et al. Rivastigmine in Parkinson’s Disease Dementia with Orthostatic Hypotension. Ann Neurol. 2020 Oct 5. doi: 10.1002/ana.25923. Epub ahead of print. PMID: 33016374.
  30. Norris SA, Jinnah HA, Klein C, Jankovic J, Berman BD, Roze E, Mahajan A, et al. Clinical and Demographic Characteristics of Upper Limb Dystonia [published online ahead of print, 2020 Aug 26]. Mov Disord. 2020;10.1002/mds.28223. PMID: 32845549
  31. Mahajan A, et al. Graduate Education Subcommittee and Education Committee of the American Academy of Neurology. Immigrant Neurologists in the United States: The Path of Most Resistance. Neurology. 2020 Nov 16:10.1212/WNL.0000000000011196. doi: 10.1212/WNL.0000000000011196. Epub ahead of print. PMID: 33199436.
  32. Duque KR, Marsili L, Sturchio A, Mahajan A, et al. Progressive Ataxia with Hemiplegic Migraines: a Phenotype of CACNA1A Missense Mutations, Not CAG Repeat Expansions [published online ahead of print, 2020 Sep 5]. Cerebellum. 2020;10.1007/s12311-020-01185-9. doi:10.1007/s12311-020-01185-9
  33. Elkasaby M, Beylergil SB, Gupta P, Mahajan A, et al. Lessons learned from the syndrome of oculopalatal tremor [published online ahead of print, 2020 Jul 18]. J Comput Neurosci. 2020;10.1007/s10827-020-00757-2. PMID: 32683665
  34. Sturchio A, Marsili L, Mahajan A, et al. How Have Advances in Genetic Technology Modified Movement Disorders Nosology? [published online ahead of print, 2020 Apr 30]. Eur J Neurol. 2020;10.1111/ene.14294. PMID: 32356310
  35. Shaikh AG, Beylergil SB, Scorr L, Kilic-Berkmen G, Freeman A, Klein C, Junker J, Loens S, Brüggemann N, Münchau A, Bäumer T, Vidailhet M, Roze E, Bonnet C, Jankovic J, Jimenez-Shahed J, Patel N, Marsh L, Comella C, et al. Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort. Neurology. 2021 Jan 26;96(4):e563-e574. doi: 10.1212/WNL.0000000000011049. Epub 2020 Oct 12. PMID: 33046615
  36. Junker J, Berman BD, Hall J, Wahba DW, Brandt V, Perlmutter JS, Jankovic J, Malaty IA, Wagle Shukla A, Reich SG, Espay AJ, Duque KR, Patel N, et al. Quality of life in isolated dystonia: non-motor manifestations matter. Neurol Neurosurg Psychiatry. 2021 Feb 9:jnnp-2020-325193. doi: 10.1136/jnnp-2020-325193. Online ahead of print.PMID: 33563813
  37. Karl JA, Ouyang B, Goetz S, Metman LV. A Novel DBS Paradigm for Axial Features in Parkinson’s Disease: A Randomized Crossover Study. Movement Disorders. 2020;351369-1378. doi:10.1002/mds.28048 PMID: 32246798
  38. Merola A, Romagnolo A, Krishna V, Pallavaram S, Carcieri S, Goetz S, Mandybur G, Duker AP, Dalm B, Rolston JD, Fasano A, Verhagen L. Current Directions in Deep Brain Stimulation for Parkinson s Disease Directing Current to Maximize Clinical Benefit. Neurology and Therapy. 2020;925-41. doi:10.1007/s40120-020-00181-9 PMID: None
  39. Bolier E, Bot M, van den Munckhof P, Pal G, Sani S, Metman LV. The medial subthalamic nucleus border as a new anatomical reference in stereotactic neurosurgery for Parkinson s disease. Stereotactic and Functional Neurosurgery. 2020;doi:10.1159/000510802 PMID: 33207350
  40. Witek N, Hawkins J, Hall D. Genetic ataxias: update on classification and diagnostic approaches. Current Neurology and Neuroscience Reports. Submitted April 2020, Pending review
  41.  Witek NP, Goetz CG, Stebbins GT. Preface. Int Rev Neurobiol. 2020;153:xi-xii. doi: 10.1016/S0074-7742(20)30100-8.
  42. Cisneros E, Stebbins GT, Chen Q, Vu JP, Benadof CN, Zhang Z, Barbano RL, Fox SH, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Adler CH, Factor SA, Reich SG, Rodriguez R, Severt LL, Stover NP, Berman BD, Comella CL, et al. It’s tricky: Rating alleviating maneuvers in cervical dystonia. Journal of the Neurological Sciences. 2020;419doi:10.1016/j.jns.2020.117205 PMID: 33160248
  43. Siuda J, Boczarska-Jedynak M, Budrewicz S, Dulski J, Figura M, Fiszer U, Gajos A, Agnieszka-Gorzkowska E, Koziorowska-Gawron D, Koziorowski A, Krygowska-Wajs M, Rudzinska-Bar J, Slawek X, Ren S, Luo P, Martinez-Martin G, Stebbins CG, Goetz G, et al. Validation of the Polish version of the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS). Neurologia i Neurochirurgia Polska. 2020;54(5):416-425. doi:10.5603/PJNNS.a2020.0049 PMID: 32639019
  44. Fraint A, Stebbins GT, Pal G, Comella CL. Reliability, feasibility and satisfaction of telemedicine evaluations for cervical dystonia. Journal of Telemedicine and Telecare. 2020;26(9):560-567. doi:10.1177/1357633X19853140 PMID: 31208263
  45. Lang AE, Stebbins GT, et al. The Cortical Basal ganglia Functional Scale (CBFS): Development and preliminary validation. Parkinsonism and Related Disorders. 2020;79121-126. doi:10.1016/j.parkreldis.2020.08.021 PMID: 32947108
  46. Merola A, Torres-Russotto DR, Stebbins GT, et al. Development and Validation of the Orthostatic Tremor Severity and Disability Scale (OT-10). Movement Disorders. 2020;351796-1801. doi:10.1002/mds.28142 PMID: 32562441
  47. de Siqueira Tosin MH, Goetz CG, Luo S, Choi D, Stebbins GT. Item Response Theory Analysis of the MDS-UPDRS Motor Examination: Tremor vs. Nontremor Items. Movement Disorders. 2020;351587-1595. doi:10.1002/mds.28110 PMID: 32469456
  48. Bolier E, Bot M, van den Munckhof P, Pal G, Sani S, Stebbins GT, Verhagen Metman L. Kinesthetic Cells within the Subthalamic Nucleus and Deep Brain Stimulation for Parkinson Disease. World Neurosurgery. 2020;139e784-e791. doi:10.1016/j.wneu.2020.04.160 PMID: 32371080
  49. Goetz CG, Stebbins GT, et al. Movement Disorder Society Unified Parkinson’s Disease Rating Scale Use in the Covid-19 Era. Movement Disorders. 2020;35911. doi:10.1002/mds.28094 PMID: 32320498
  50. Pick S, Anderson DG, Asadi-Pooya AA, Aybek S, Baslet G, Bloem BR, Nicholson TR, Bradley-Westguard A, Brown RJ, Carson AJ, Chalder T, Damianova M, David AS, Edwards MJ, Epstein SA, Espay AJ, Garcin B, Goldstein LH, Hallett M, Jankovic J, Joyce EM, Kanaan RA, Keynejad RC, Kozlowska K, Lafaver K, Lafrance WC, Lang AE, Lehn A, Lidstone S, Maurer CW, Stebbins G, PhD. Mildon B, Morgante F, Myers L, Nicholson C, Nielsen G, Perez DL, Popkirov S, Reuber M, Rommelfanger KS, Schwingenshuh P, Serranova T, Shotbolt P, Stebbins GT, et al. Outcome measurement in functional neurological disorder: A systematic review and recommendations. Journal of Neurology, Neurosurgery and Psychiatry. 2020;91638-649. doi:10.1136/jnnp-2019-322180 PMID: 32111637
  51. Bernard BA, Carns D, Stebbins GT, Goldman JG, Goetz CG. Relationship of Movement Disorders Society Unified Parkinson’s Disease Rating Scale Nonmotor Symptoms to Cognitive Functioning in Patients with Parkinson’s Disease. Movement Disorders Clinical Practice. 2020;7279-283. doi:10.1002/mdc3.12902 PMID: None
  52. Piot I, Schweyer K, Respondek G, Stamelou M, Sckopke P, Schenk T, Goetz CG, Stebbins GT, et al. The Progressive Supranuclear Palsy Clinical Deficits Scale. Movement Disorders. 2020;35650-661. doi:10.1002/mds.27964 PMID: 31951049
  53. Chen Q, Vu JP, Cisneros E, Benadof CN, Zhang Z, Barbano RL, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Appelbaum MI, Stebbins GT, Comella CL, et al. Postural directionality and head tremor in cervical dystonia. Tremor and Other Hyperkinetic Movements. 2020;101-6. doi:10.7916/tohm.v0.745 PMID: 32015932
  54. Faust-Socher A, Faust-Socher A, Anis S, Kestenbaum M, Shabtai H, Taichman T, Bar David A, Ezra A, Peretz C, Rosenberg A, Brozgol M, Herman T, Stebbins GT, Goetz CG, et al. Validation of the Hebrew Version of the Unified Dyskinesia Rating Scale. Neuroepidemiology. 2020;doi:10.1159/000507827 PMID: 32541146
  55. Espay AJ, Kalia LV, Gan-Or Z, Williams-Gray CH, Bedard PL, Rowe SM, Morgante F, Fasano A, Stecher B, Kauffman MA, Farrer MJ, Coffey CS, Schwarzschild MA, Sherer T, Postuma RB, Strafella AP, Singleton AB, Barker RA, Kieburtz K, Olanow CW, Lozano A, Kordower JH, et al. Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? Neurology. 2020 Mar 17;94(11):481-494. doi:10.1212/WNL.0000000000009107. Epub 2020 Feb 26.PMID: 32102975
  56. Dodiya HB, Forsyth CB, Voigt RM, Engen PA, Patel J, Shaikh M, Green SJ, Naqib A, Roy A, Kordower JH, et al. Chronic stress-induced gut dysfunction exacerbates Parkinson’s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson’s disease. Neurobiol Dis. 2020 Feb;135:104352. doi: 10.1016/j.nbd.2018.12.012. Epub 2018 Dec 21. PMID: 30579705
  57. Harms AS, Kordower JH, et al. Inflammation in Experimental Models of α-Synucleinopathies. Mov Disord. 2021 Jan;36(1):37-49. doi: 10.1002/mds.28264. Epub 2020 Oct 3. PMID: 33009855
  58. Song B, Cha Y, Ko S, Jeon J, Lee N, Seo H, Park KJ, Lee IH, Lopes C, Feitosa M, Luna MJ, Jung JH, Kim J, Hwang D, Cohen BM, Teicher MH, Leblanc P, Carter BS, Kordower JH, et al. Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson’s disease models. J Clin Invest. 2020 Feb 3;130(2):904-920. doi: 10.1172/JCI130767. PMID:31714896
  59. Barker RA, Björklund A, Gash DM, Whone A, Van Laar A, Kordower JH, et al. GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop. J Parkinsons Dis. 2020;10(3):875-891. doi: 10.3233/JPD-202004. PMID: 32508331
  60. Albin RL, Kordower JH. A Failed Future. Mov Disord. 2020 Aug;35(8):1299-1301. doi: 10.1002/mds.28130. PMID: 32780511
  61. Williams GP, Marmion DJ, Schonhoff AM, Jurkuvenaite A, Won WJ, Standaert DG, Kordower JH, et al. T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease. Acta Neuropathol. 2020 May;139(5):855-874. doi: 10.1007/s00401-020-02126-w. Epub 2020 Jan 29. PMID: 31993745
  62. Alarcón-Arís D, Pavia-Collado R, Miquel-Rio L, Coppola-Segovia V, Ferrés-Coy A, Ruiz-Bronchal E, Galofré M, Paz V, Campa L, Revilla R, Montefeltro A, Kordower JH, et al. Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson’s disease-like mouse model and in monkeys. EBioMedicine. 2020 Sep;59:102944. doi: 10.1016/j.ebiom.2020.102944. Epub 2020 Aug 15. PMID: 32810825.
  63. Sellnow RC, Steece-Collier K, Altwal F, Sandoval IM, Kordower JH, et al. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson’s Disease. J Neurosci. 2020 Apr 29;40(18):3675-3691. doi: 10.1523/JNEUROSCI.2936-19.2020. Epub 2020 Apr 1. PMID: 32238479
  64. Kordower JH, et al. Reply to: “Toward a Personalized Approach to Parkinson’s Cell Therapy”. Mov Disord. 2020 Nov;35(11):2120-2121. doi: 10.1002/mds.28329. PMID: 33463751
  65. Jankovic J, Okun MS, Kordower JH. Stem Cells: Scientific and Ethical Quandaries of a Personalized Approach to Parkinson’s Disease. Mov Disord. 2020 Aug;35(8):1312-1314. doi: 10.1002/mds.28187. Epub 2020 Jul 7. PMID: 32529662
  66. Von Linstow CU, DeLano-Taylor M, Kordower JH, et al. Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson’s Disease? J Parkinsons Dis. 2020;10(2):405-411. doi: 10.3233/JPD-191877. PMID: 31958098
  67. Chu Y, Bartus RT, Manfredsson FP, Olanow CW, Kordower JH. Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson’s disease. Brain. 2020 Mar 1;143(3):960-975. doi: 10.1093/brain/awaa020. PMID: 32203581
  68. Gluncic V, Moric M, Chu Y, Hanko V, Li J, Lukić IK, Lukić A, Edassery SL, Kroin JS, Persons AL, Perry P, Kelly L, Shiveley TJ, Nice K, Napier TC, Kordower JH, et al. Corrigendum to: In Utero Exposure to Anesthetics Alters Neuronal Migration Pattern in Developing Cerebral Cortex and Causes Postnatal Behavioral Deficits in Rats. Cereb Cortex. 2020 Jul 30;30(9):5190. doi: 10.1093/cercor/bhz234. PMID: 32567651
  69. Ohene-Nyako, M., A.L. Persons and T.C. Napier. Hippocampal blood-brain barrier of methamphetamine self-administering HIV-1 transgenic rats.  European Journal of Neuroscience, July 29, 2020.  doi: 10.1111/ejn.14925. PMID: 32725911
  70. Napier, T.C., A. Kirby et al. Dopamine pharmacotherapy and addiction-like behaviors in Parkinson’s disease.  Invited review. Special issue of Progress in Neuro-Psychopharmacology & Biological Psychiatry: Commonalities in the neurobiological and psychological underpinnings of gambling disorder and drug abuse.  Issue Eds:  P. Anselme, M. Robinson, B. Singer and P. Vezina. Aug 30;102:109942, 2020. doi: 10.1016/j.pnpbp.2020.109942  PMID: 32272129.
  71. Bradaric, B.D., A. Kirby and T.C. Napier. Integrating neurology and psychiatry throughout educational curricula for healthcare professionals. Journal of Experimental Neurology 1(4):168-172, 2020.
  72. Zasadil CT, O’Keefe JA, et al. Evaluating Anticipated and Unanticipated Turns Using Multiple Inertial Measurement Units Outside of the Lab, J. Biomechanics, 2020.
  73. Voss S, Zampieri, C Biskis, A, Ouyang B, Liu Y, Purcell N, Berry-Kravis E, O’Keefe JA. Normative database of postural sway measures using inertial sensors in typically developing children and young adults. PMID: 32531757. PMCID: PMC7388584
  74. Robertson EE, Hall DA, Pal G, Bichun Ouyang B, Liu Y, Joyce JM, Berry-Kravis E, O’Keefe JA. Tremorography in fragile X-associated tremor/ataxia syndrome, Parkinson’s disease and essential tremor; Clin Parkinsonism Rel Disord, 2020; Volume 3. https://doi.org/10.1016/j.prdoa.2020.100040
  75. Voss S, Joyce JA, Biskis, A, Armajo N, Tracy R, Palmer A, Ouyang B, Liu Y, Parulekar M, Fefferman M, Berry-Kravis E, O’Keefe JA. Inertial sensor based normative spatiotemporal gait parameters in typically developing children and young adults, Gait & Posture, 2020; Jul;80:206-213. PMID: 32531757
  76. Gera A , O’Keefe JA, et al. Gait asymmetry in glucocerebrosidase mutation carriers with Parkinson’s disease. PLoS One. 2020 Jan 24;15(1):e0226494. doi: 10.1371/journal.pone.0226494. eCollection 2020. PMID: 31978134
  77. Purcell N, Goldman JG, Bernard B, O’Keefe JA. The effects of dual-task cognitive interference on gait and turning in Huntington’s disease; PLoS One. 2020 Jan 7;15(1):e0226827. doi: 10.1371/journal.pone.0226827. eCollection 2020. PMID: 31910203
  78. Hall DA, Robertson E., Leehey M, McAsey A, Ouyang B, Berry-Kravis E, O’Keefe JA. Open-label pilot trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS); PLoS One. 2020 Feb 13;15(2):e0225191. doi: 10.1371/journal.pone.0225191. eCollection 2020. PMID: 32053612